Stock Analysis on Net
AI Tokens
Stock Analysis on Net

Allergan PLC (NYSE:AGN)

This company has been moved to the archive! The financial data has not been updated since May 7, 2020.

Common-Size Income Statement
Quarterly Data

Allergan PLC, common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Net revenues 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost of sales, excludes amortization and impairment of acquired intangibles including product rights -17.29 -16.18 -15.78 -15.95 -13.84 -14.46 -15.26 -11.68 -14.24 -13.43 -14.54 -13.73 -12.61 -12.41 -12.76 -11.98 -14.04 -15.66 -30.40 -37.01 -39.81
Gross profit 82.71% 83.82% 84.22% 84.05% 86.16% 85.54% 84.74% 88.32% 85.76% 86.57% 85.46% 86.27% 87.39% 87.59% 87.24% 88.02% 85.96% 84.34% 69.60% 62.99% 60.19%
Research and development -11.93 -10.40 -11.71 -11.00 -12.09 -16.62 -10.85 -16.71 -12.93 -9.44 -10.97 -12.21 -21.27 -23.63 -17.19 -17.27 -11.86 -12.21 -30.83 -7.90 -12.40
Selling and marketing -26.97 -20.29 -22.25 -21.35 -22.35 -20.63 -19.32 -20.69 -21.79 -20.29 -20.64 -23.34 -24.32 -21.65 -21.98 -23.52 -22.56 -24.08 -17.65 -17.05 -22.23
General and administrative -11.13 -17.39 -26.98 -7.93 -8.57 -8.63 -7.39 -8.10 -8.06 -8.99 -8.35 -11.47 -8.85 -11.39 -9.97 -9.31 -9.69 -14.77 -8.59 -8.34 -21.09
Amortization -39.30 -34.88 -37.96 -34.28 -38.90 -38.46 -40.61 -41.15 -46.23 -44.43 -44.15 -43.87 -48.59 -42.40 -44.42 -44.32 -46.77 -53.74 -38.16 -29.08 -30.74
Goodwill impairments -25.33 0.00 0.00 -26.55 -68.58 -69.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
In-process research and development impairments 0.00 0.00 0.00 -10.66 0.00 -0.16 0.00 -6.69 -14.22 -4.78 -5.01 -17.55 -9.52 -11.05 -1.16 -7.30 -0.18 -0.53 -7.34 -3.43 0.00
Asset sales and impairments, net -4.11 -7.22 -0.05 -3.16 0.14 -63.37 0.01 -6.29 -0.36 -0.73 -96.05 -0.35 -0.21 -0.75 0.13 0.48 0.05 -10.18 0.11 -0.01 -0.18
Operating income (loss) -36.06% -6.36% -14.73% -30.88% -64.20% -131.97% 6.58% -11.32% -17.81% -2.09% -99.70% -22.52% -25.36% -23.29% -7.35% -13.23% -5.05% -31.17% -32.86% -2.83% -26.45%
Interest income 0.59 0.58 0.51 0.24 0.59 0.28 0.26 0.15 0.47 0.34 0.28 0.41 0.71 1.20 0.50 0.07 0.09 0.12 0.09 0.05 0.07
Interest expense -5.12 -4.41 -4.79 -4.78 -5.61 -5.15 -5.63 -5.58 -6.82 -6.09 -6.57 -6.92 -8.11 -7.57 -8.95 -9.38 -9.79 -12.81 -8.32 -5.91 -6.71
Other income (expense), net -0.69 0.49 0.06 -0.11 0.38 -0.24 3.32 5.22 -2.15 -1.63 -32.48 -3.33 -53.82 0.91 0.93 4.07 0.01 0.47 0.00 -0.85 -7.72
Other income (expense), net -5.22% -3.34% -4.22% -4.66% -4.63% -5.11% -2.06% -0.20% -8.50% -7.38% -38.78% -9.84% -61.22% -5.47% -7.53% -5.24% -9.69% -12.22% -8.22% -6.71% -14.36%
Income (loss) before income taxes and noncontrolling interest -41.28% -9.70% -18.95% -35.53% -68.83% -137.08% 4.53% -11.52% -26.31% -9.47% -138.48% -32.36% -86.57% -28.76% -14.88% -18.48% -14.74% -43.38% -41.08% -9.54% -40.81%
(Provision) benefit for income taxes 51.79 2.41 -0.45 -7.37 1.91 31.78 -5.46 0.13 18.58 90.57 40.62 14.50 14.89 27.72 4.39 7.01 12.02 6.41 20.17 5.34 10.11
Net income (loss) from continuing operations, net of tax 10.51% -7.29% -19.39% -42.91% -66.92% -105.30% -0.93% -11.40% -7.73% 81.10% -97.86% -17.85% -71.68% -1.04% -10.49% -11.47% -2.71% -36.98% -20.91% -4.20% -30.70%
Income (loss) from discontinued operations, net of tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -8.91 -0.15 -0.21 -0.09 1.07 430.73 -2.10 10.26 13.36 150.59 0.00 10.71
Net income (loss) 10.51% -7.29% -19.39% -42.91% -66.92% -105.30% -0.93% -11.40% -7.73% 72.19% -98.01% -18.06% -71.77% 0.03% 420.24% -13.57% 7.54% -23.62% 129.68% -4.20% -19.99%
(Income) loss attributable to noncontrolling interest -0.03 0.00 -0.03 -0.10 -0.02 -0.10 -0.04 -0.06 -0.06 -0.04 -0.04 -0.05 -0.03 -0.05 -0.05 -0.05 -0.02 -0.06 -0.03 -0.03 0.01
Net income (loss) attributable to shareholders 10.49% -7.29% -19.42% -43.01% -66.94% -105.40% -0.97% -11.46% -7.79% 72.15% -98.05% -18.11% -71.80% -0.02% 420.19% -13.62% 7.52% -23.68% 129.65% -4.22% -19.98%
Dividends on preferred shares 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.26 -1.61 -1.73 -1.74 -1.95 -1.80 -1.92 -1.89 -2.05 -2.61 -1.70 -1.21 -0.91
Net income (loss) attributable to ordinary shareholders 10.49% -7.29% -19.42% -43.01% -66.94% -105.40% -0.97% -11.46% -9.05% 70.54% -99.78% -19.85% -73.74% -1.82% 418.27% -15.50% 5.47% -26.29% 127.95% -5.43% -20.89%

Based on: 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31).

The financial profile is characterized by a significant expansion in gross margins during the first half of 2015, followed by a period of relative stability. However, this operational efficiency is consistently offset by substantial non-cash charges, including high amortization expenses and periodic, large-scale impairment losses, which have frequently resulted in negative operating income.

Gross Profitability and Cost of Sales
A marked improvement in gross margin is observed from March 2015 (60.19%) through December 2015, where it reached 84.34%. For the remainder of the analyzed period, gross profit remained consistently high, generally fluctuating between 82% and 88%. This trend indicates a substantial reduction in the cost of sales as a percentage of net revenues, which dropped from approximately 40% in early 2015 to a range of 12% to 17% in subsequent years.
Operating Expense Trends
Selling and marketing expenses remained relatively stable, typically ranging between 17% and 24% of net revenues, with a peak of 26.97% in March 2020. General and administrative expenses were generally contained between 7% and 12% for most of the period, though a significant outlier occurred in September 2019, where expenses spiked to 26.98%. Research and development spending exhibited high volatility, peaking at 30.83% in September 2015 before settling into a more consistent range of 10% to 20%.
Amortization and Impairment Impact
Amortization represents a heavy and persistent burden on the income statement, consistently consuming between 34% and 53% of net revenues. This is compounded by severe goodwill impairments that materialized in the later stages of the period, specifically in December 2018 (-69.64%), March 2019 (-68.58%), and June 2019 (-26.55%). Additionally, asset sales and impairments caused extreme volatility, most notably a 96.05% hit in September 2017 and a 63.37% hit in December 2018.
Operating and Net Income Volatility
Operating income was predominantly negative throughout the period, with losses deepening significantly during quarters with high impairment charges, such as December 2018 (-131.97%). Net income figures were highly erratic due to the influence of discontinued operations, which provided massive positive offsets in September 2015 (150.59%) and September 2016 (430.73%). Excluding these anomalous gains, the net income attributable to shareholders remained largely negative, reflecting the impact of high amortization and asset write-downs.
Financial Costs and Tax Effects
Interest expenses remained relatively stable, gradually declining from 6.71% of net revenues in March 2015 to approximately 5.12% by March 2020. The provision or benefit for income taxes fluctuated wildly, often providing significant tax benefits during quarters of heavy operating losses, such as the 90.57% benefit recorded in December 2017 and the 51.79% benefit in March 2020.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?